Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
53.67
+0.27 (0.51%)
At close: May 13, 2025, 4:00 PM
53.49
-0.18 (-0.34%)
Pre-market: May 14, 2025, 4:01 AM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Total Screening | 2.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Screening Growth | 14.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Medicare Parts B & C | 804.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Medicare Parts B & C Growth | 14.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Commercial | 1.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Commercial Growth | 13.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Other Service | 216.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Screening Other Service Growth | 20.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Medicare Parts B & C | 186.11M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Medicare Parts B & C Growth | -1.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Commercial | 192.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Commercial Growth | 4.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology International | 196.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology International Growth | 22.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Other Service | 84.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Precision Oncology Other Service Growth | -18.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Precision Oncology | 659.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Precision Oncology Growth | 3.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 Testing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 Testing Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| United States | 2.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 10.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States | 196.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States Growth | 22.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| United States Income Before Tax |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Income Before Tax Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States Income Before Tax |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Outside of United States Income Before Tax Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|